Shell Asset Management CO Voyager Therapeutics, Inc. Transaction History

Shell Asset Management CO

  • $2.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$3.94 - $5.44 $339,107 - $468,209
-86,068 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$4.61 - $9.04 $193,836 - $380,104
42,047 Added 95.52%
86,068 $405,000
Q4 2020

Feb 16, 2021
BUY
$7.15 - $12.28 $236,343 - $405,915
33,055 Added 301.43%
44,021 $315,000
Q2 2020

Aug 10, 2020
BUY
$8.05 - $14.21 $88,276 - $155,826
10,966 New
10,966 $138,000

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $207M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email